Peter S. Kim

Companies

• Entrada Therapeutics, Inc.Board member Oct 28, 2021 to now¹
• Merck & Co.Exec. V-P and Pres., MRL Nov 5, 2009 to Feb 27, 2013²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEntrada Therapeutics, Inc. TRDA104,330 shares³$512.8K at $4.92Jun 3, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 3, 2024Exercised options 11,918 shares at $6.06 of Entrada Therapeutics, Inc.³
• May 14, 2024Bought 25,000 shares at $14.59 of Entrada Therapeutics, Inc.⁴
• May 14, 2024Bought 25,000 shares at $14.59 of Entrada Therapeutics, Inc.⁵
• May 13, 2024Bought 25,000 shares at $14.68 of Entrada Therapeutics, Inc.⁴
• May 9, 2024Bought 2,200 shares at $14.25 of Entrada Therapeutics, Inc.⁶
• May 8, 2024Bought 2,276 shares at $14.04 of Entrada Therapeutics, Inc.⁶
• Apr 8, 2024Bought 2,600 shares at $13.57 of Entrada Therapeutics, Inc.⁷
• Mar 28, 2024Bought 1,512 shares at $13.75 of Entrada Therapeutics, Inc.⁸
• Mar 26, 2024Bought 2,750 shares at $13.64 of Entrada Therapeutics, Inc.⁹
• Mar 25, 2024Bought 3,180 shares at $13.36 of Entrada Therapeutics, Inc.⁹
• Mar 22, 2024Bought 3,118 shares at $13.76 of Entrada Therapeutics, Inc.⁹
• Mar 21, 2024Bought 704 shares at $13.24 of Entrada Therapeutics, Inc.¹⁰
• Mar 20, 2024Bought 1,128 shares at $12.66 of Entrada Therapeutics, Inc.¹⁰
• Mar 19, 2024Bought 900 shares at $12.66 of Entrada Therapeutics, Inc.¹⁰